01Impact factor
Impact factor of Revista Española de Quimioterapia (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Revista Española de Quimioterapia published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, calculated by ScholarsColab. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Pharmacology & Pharmacyrank 266 of 371 journals
- Microbiologyrank 140 of 171 journals
Ranks here compare journals of the same Web of Science category in our data by 2-year citedness; they are not the official JCR rank.
Quartile of Revista Española de Quimioterapia
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Revista Española de Quimioterapia is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Citations and papers per year
Open access (listed in DOAJ).
Is your paper a fit for Revista Española de Quimioterapia?
Most desk rejections come from a scope mismatch. Compare your title and abstract with what this journal really publishes. Free, no sign-up, about 2 minutes.
Check my paper for this journalOr find journals that fit my paper
Need a faster review? The fastest journals in Pharmacology & Pharmacy accept papers in a median of 3 days.
APC waivers and discounts for Revista Española de Quimioterapia
No published waiver policy found for its publisher. Ask the editorial office, and compare publishers that do waive the APC.
02Funders
Who funds research published in Revista Española de Quimioterapia
A high share of funded papers usually means the journal is a common choice for grant-supported work in its field. If your funder pays article processing charges, or your country qualifies for a waiver, check what applies to your author team with the free APC waiver checker.
03Indexing
Indexing of Revista Española de Quimioterapia
- ISSN
- 0214-3429
- eISSN
- 1988-9518
- Publisher
- Sociedad Española de Quimioterapia
- Subjects
- Microbiology, Pharmacology & Pharmacy
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor on this page is calculated by ScholarsColab (see how the impact factor works).
- Web of Science Master Journal List
- SCImago Journal Rank
- ISSN Portal (ISSN 0214-3429)
- DOAJ (Directory of Open Access Journals)
Each link opens the official record for this journal, searched by its ISSN where we have one.
04How to submit
How to submit to Revista Española de Quimioterapia
- Read the guide for authors. It sets the article types, word limit, reference style and file format that Revista Española de Quimioterapia accepts. You find it on the journal's website at Sociedad Española de Quimioterapia, usually under "For authors".
- Format to the journal's style. Check whether it wants a Word file, a LaTeX file or a PDF for the first submission, and follow its reference style; many journals accept any clear format at first and ask for their style only after acceptance. If the language or structure needs work first, manuscript editing by a PhD editor in your field is priced by word count (see the editing cost guide).
- Check the fit. Read the aims and scope and a few recent issues; papers outside the scope are the most common reason for a desk rejection. The Journal Finder shows journals that published the closest work.
- Plan the fee. Revista Española de Quimioterapia is fully open access and lists no article fee in DOAJ. See whether your author team qualifies for a waiver with the free APC waiver checker.
- Check your manuscript before you submit. The free Submission Readiness Check asks the seven questions our reviewers ask in every audit and takes about 2 minutes.
05Reviewer comments
Reviewer comments and rejection reasons for Revista Española de Quimioterapia
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Revista Española de Quimioterapia, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Worried about the English? Manuscript editing by editors in your subject: see the price →
Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 seconds06Same subject
Pharmacology & Pharmacy journals with a similar impact factor*
The journals next to Revista Española de Quimioterapia when the 354 journals of Pharmacology & Pharmacy in our data are ranked by impact factor*:
| Rank | Journal | Impact factor* | Indexing | Open access |
|---|---|---|---|---|
| 262 | Turkish Journal of Pharmaceutical Sciences | 1.54 | ESCI | Some open access |
| 263 | Journal of Pharmacy And Bioallied Sciences | 1.54 | ESCI | Fully open access |
| 264 | Clinical Pharmacology in Drug Development | 1.53 | SCIE | Subscription |
| 265 | Current Drug Safety | 1.51 | ESCI | Subscription |
| 267 | Endocrine Metabolic & Immune Disorders - Drug Targets | 1.50 | SCIE | Subscription |
| 268 | American Journal of Health-System Pharmacy | 1.48 | SCIE | Subscription |
| 269 | Iranian journal of pharmaceutical research | 1.42 | SCIE | Subscription |
| 270 | Indian Journal of Pharmaceutical Education and Research | 1.41 | SCIE | Subscription |
*Impact factor calculated by ScholarsColab (2-year citedness), not the official Clarivate value.
Is Revista Española de Quimioterapia right for your paper? Find the right journal
Paste your title, keywords or abstract. See the journals that published the closest papers, with indexing, impact factor, review time and APC.
No AI or language model is used. Your words are matched against the titles of 157,375 real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; the impact factor is calculated by ScholarsColab, not the official Clarivate value, and no quartile is shown until the official JCR or SJR quartile can be; review time is the median days from submission to acceptance (not every publisher publishes these dates). Always check a journal’s scope and current indexing before submitting.
07Questions
Frequently asked questions
What is the impact factor of Revista Española de Quimioterapia?
Based on ScholarsColab citation data (October 2026), the 2-year impact factor of Revista Española de Quimioterapia is 1.50: papers it published in the two previous years were cited 1.50 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Revista Española de Quimioterapia?
The h-index of Revista Española de Quimioterapia is 28 (October 2026): 28 of its papers have each been cited at least 28 times. Its i10-index is 117.
What is the quartile of Revista Española de Quimioterapia?
A journal's quartile (Q1 to Q4) is its position within a subject category: Q1 is the top quarter. The official quartiles are published by Clarivate in Journal Citation Reports (by Journal Impact Factor, in Web of Science categories) and by Scimago as the SJR quartile (in Scopus categories). Revista Española de Quimioterapia is listed in JCR 2024, so its JCR quartile is in Journal Citation Reports. It is indexed in Scopus, so Scimago shows its SJR quartile. ScholarsColab does not show a quartile until it can show the official one; the impact factor and rank above are calculated from open data.
Is Revista Española de Quimioterapia indexed in Scopus?
Yes. Revista Española de Quimioterapia appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Revista Española de Quimioterapia an SCIE journal?
Yes. Revista Española de Quimioterapia is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Revista Española de Quimioterapia in Journal Citation Reports (JCR)?
Yes. Revista Española de Quimioterapia is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
Who funds research published in Revista Española de Quimioterapia?
0% of 138 recent research articles in Revista Española de Quimioterapia name a funder.
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Inorganic Chemistry
- Macromolecules
- Chemosphere
- Biochemical and Biophysical Research Communications
- Annals of Oncology
- Physical Review B
- RSC Advances
- Review of Scientific Instruments
- Journal of Biological Chemistry
- Value in Health
- Journal of Agricultural and Food Chemistry
- International Journal of Molecular Sciences
- Journal of Animal Science
- BMJ Open
Browse all journals: indexing, impact factor and reviewer comments →